Executive Summary
Apple’s IPR resulted in the Board finding all six challenged claims of Omni MedSci’s ’299 patent unpatentable as obvious over a combination of prior‑art references covering wearable optical sensing.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in SAMSUNG ELECTRONICS CO., LTD. et al. vs OMNI MEDSCI, INC. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
QIAGEN Sciences, LLCvsTecan Group AG
QIAGEN’s response argues the PTAB correctly found material error in the examiner’s reliance on a flawed declaration and that the Board’s institution decision stands. The petition challenges the patent owner’s attempt to obtain discretionary denial based on procedural grounds.
Apple Inc.vsResonant Systems, Inc.
The PTAB denied Apple Inc.'s request to institute a parallel Inter Partes Review against Resonant Systems, Inc., finding that the existing IPR proceeding was sufficient despite arguments regarding priority date disputes.
VIZIO, Inc.vsMultimedia Technologies Pte. Ltd.
The PTAB issued a Final Written Decision finding that all challenged claims (1-14) were patentable over the prior art. The Board adopted the Patent Owner's construction of key terms like 'based on,' requiring temporal dependency on currently displayed content.
US Conec Ltd.vsSenko Advanced Components, Inc.
US Conec Ltd. challenges the validity of Senko Advanced Components' '369 patent, arguing that various claims are anticipated or rendered obvious by prior art references (Scherer, Lee, Gniadek). The petition asserts both anticipation (102) and obviousness (103), specifically targeting connector housing arrangements in optical fiber technology.
SNAP INC.vsNokia Technologies Oy
The PTAB instituted an inter partes review of Nokia’s 7,724,818 B2 video‑coding patent after Amazon demonstrated a reasonable likelihood of success on eight claims. The Board rejected discretionary denial arguments and will proceed to trial on all challenged claims.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.